Previous 10 | Next 10 |
Illumina's acquisition of Grail was received poorly - we disagree wholeheartedly with the market and see significant upside from the acquisition, which increases its addressable market by 10x. The company is dominant, with a ~70% market share, and is the global market leader in next-g...
A weekly summary of dividend activity for Dividend Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Challenger Highlights: Week Of October 25
LC instruments receive ACT labels from My Green Lab Agilent Technologies Inc. (NYSE: A) today announced that their 1220, 1260, and 1290 Infinity II LC product families have received the My Green Lab accountability, consistency, and transparency (ACT) certification. Recogniti...
Faster testing for pharma and biopharma to meet increasingly stringent regulations Agilent Technologies Inc. (NYSE: A) today announced that the Agilent Vaya Raman raw material identity verification system has received a 2020 R&D 100 Award in the Analytical/Test categ...
As I noted in my 9/27/2020 column, the “V” bottom that I thought was possible has materialized. Although the US stock market is still volatile with large swings influenced by daily news reports and politically related items, the uptrend is back until proven otherwise, states Joe...
Washington University School of Medicine in St. Louis professor recognized for research in cellular immunotherapy Agilent Technologies Inc. (NYSE: A) today announced that Carl DeSelm, M.D., Ph.D., has received the 2020 Agilent Early Career Professor Award. Dr. DeSelm is ...
An exciting development for digital pathology Agilent Technologies Inc. (NYSE: A) today announced the expansion of Visiopharm’s validated image analysis algorithm to incorporate HercepTest™ mAb pharmDx for Dako Omnis, both CE-IVD marked and recently released for sa...
Like every week on my TEV blog, I want to show you some stocks that will go ex-dividend in the next few days. This time, I will take a closer look at John Wiley & Sons and General Mills. Compared to John Wiley & Sons, the risk/reward ratio at General Mills is, in my opinio...
This article is part of a series that provides an ongoing analysis of the changes made to Harris Associates' 13F stock portfolio on a quarterly basis. It is based on Harris Associates’ regulatory 13F Form filed on 08/14/2020. William Nygren’s 13F portfolio value increased ~14...
I remember exactly when I became aware of robotic surgery: I was four years old, watching Luke Skywalker have his hand rebuilt after a rather contentious family reunion. That level of science fiction has not yet become reality, but we're not as far away as we once were. Intuitive Surgical (N...
News, Short Squeeze, Breakout and More Instantly...
Agilent Technologies Inc. Company Name:
A Stock Symbol:
NYSE Market:
Agilent Technologies Inc. Website:
Technology helps high-throughput labs operate more efficiently Agilent Technologies Inc. (NYSE: A) today announced it has acquired Sigsense Technologies , a San Francisco, California-based startup that uses artificial intelligence and power monitoring to help optimize lab operatio...
Expands Agilent’s end-to-end biopharma solutions that accelerate drug discovery, development, and manufacturing Agilent Technologies Inc. (NYSE: A) today announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturin...
2024-07-21 07:07:00 ET At long last, Europe has a space rocket, the Ariane 6, able to compete with SpaceX and its ubiquitous Falcon 9. The Ariane 6 isn't a reusable rocket, it arrived four years later than it was supposed to, and it probably costs about twice as much as a Falcon. But fo...